Insulin glargine, recombinant Subcutaneous and Pregabalin Extended-Release Tablets
Determining the interaction of Insulin glargine, recombinant Subcutaneous and Pregabalin Extended-Release Tablets and the possibility of their joint administration.
No interaction was detected between the selected drugs or effects of joint drug administration are currently understudied, and it takes time and accumulated statistics to determine their interaction. A doctor should be consulted to address the issue of joint drug administration.
Generic Name: insulin glargine
Brand name: Basaglar KwikPen, Lantus, Lantus Solostar Pen, Toujeo SoloStar, Lantus OptiClik Cartridge, Toujeo Max SoloStar, Lantus SoloStar
Synonyms: Insulin glargine, Insulin Glargine
Generic Name: pregabalin
Brand name: Lyrica, Lyrica CR
Synonyms: Pregabalin
In the course of checking the drug compatibility and interactions, data from the following reference sources was used: Drugs.com, Rxlist.com, Webmd.com, Medscape.com.
- Insulin glargine, recombinant Subcutaneous-Pregabalin Oral Solution
- Insulin glargine, recombinant Subcutaneous-Pregnyl
- Insulin glargine, recombinant Subcutaneous-Pregnyl injectable
- Insulin glargine, recombinant Subcutaneous-Prelidopine Pre-Operative System
- Insulin glargine, recombinant Subcutaneous-Prelone
- Insulin glargine, recombinant Subcutaneous-Prelu-2
- Pregabalin Extended-Release Tablets-Insulin glulisine
- Pregabalin Extended-Release Tablets-Insulin Glulisine (Cartridges and Pens)
- Pregabalin Extended-Release Tablets-Insulin Glulisine (Vials)
- Pregabalin Extended-Release Tablets-Insulin glulisine Subcutaneous
- Pregabalin Extended-Release Tablets-Insulin human inhaled Inhalation
- Pregabalin Extended-Release Tablets-Insulin human regular Injection